Jennifer Anne Doudna (born February 19, 1964)[2] is an ... - dofaq.co
Jennifer Anne Doudna (born February 19, 1964)[2] is an ...
wikipedia - 10 Oct 2020
Jennifer Anne Doudna (born February 19, 1964)[2] is an American biochemist known for her pioneering work in CRISPR gene editing, for which she was awarded the 2020 Nobel Prize in Chemistry along with Emmanuelle Charpentier. She is a Li Ka Shing Chancellor Chair Professor in the Department of Chemistry and the Department of Molecular and Cell Biology at the University of California, Berkeley.[3]
What's the timeline for gene edited babies? 25 years, says CRISPR pioneer Jennifer Doudna
Genetic Literacy Project - 28 Apr 2022
What's the timeline for gene edited babies? 25 years, says CRISPR pioneer Jennifer Doudna ...
Scientific collaborations are precarious territory for women
Nature.com - 03 May 2022
Scientific collaborations are precarious territory for women ...
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Nature.com - 18 May 2022
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination ...
Most influential people in biopharma, the scientists
FiercePharma - 09 May 2022
Most influential people in biopharma, the scientists ...
Karen Miga named one of TIME's 100 most influential people of 2022
University of California - 26 May 2022
Karen Miga named one of TIME's 100 most influential people of 2022 ...
Nobel Laureate Dr. Jennifer Doudna and Groundbreaking Applications of CRISPR - Research Blog
researchblog.duke.edu - 29 Nov 2021
Nobel Laureate Dr. Jennifer Doudna and Groundbreaking Applications of CRISPR - Research Blog ...
Ginsburg Symposium hosts discussions about precision medicine technologies
Daily Bruin - 16 May 2022
Ginsburg Symposium hosts discussions about precision medicine technologies ...
Making science serve humanity: Jennifer Doudna, PhD, says CRISPR gene-editing technology should be accessible to all
AAMC - 08 Nov 2021
Making science serve humanity: Jennifer Doudna, PhD, says CRISPR gene-editing technology should be accessible to all ...
Biogen takes another dip into Scribe gene therapy collab with another disease target
FierceBiotech - 02 May 2022
Biogen takes another dip into Scribe gene therapy collab with another disease target ...
Jennifer Doudna and Marty Chavez on where CRISPR meets Wall Street
STAT - 18 Feb 2022
Jennifer Doudna and Marty Chavez on where CRISPR meets Wall Street ...
Dynamoid secures NIH funding to bring science to the metaverse
PR Newswire - 24 May 2022
Dynamoid secures NIH funding to bring science to the metaverse ...
Sixth Street taps Nobel Laureate Doudna as chief science advisor
PE Hub - 08 Feb 2022
Sixth Street taps Nobel Laureate Doudna as chief science advisor ...
Nobel laureate Jennifer Doudna is using CRISPR to build an network of women scientists - San Francisco Business Times
The Business Journals - 04 Mar 2022
Nobel laureate Jennifer Doudna is using CRISPR to build an network of women scientists - San Francisco Business Times ...
Jennifer Doudna-founded CRISPR biotech raises new cash to broaden drug development work
BioPharma Dive - 09 Sep 2021
Jennifer Doudna-founded CRISPR biotech raises new cash to broaden drug development work ...
Nobel Prize Winner Dr. Jennifer A. Doudna to Receive Top Award from the Women in Medicine Legacy Foundation
GlobeNewswire - 12 Oct 2021
Nobel Prize Winner Dr. Jennifer A. Doudna to Receive Top Award from the Women in Medicine Legacy Foundation ...
CRISPR Co-Founder Jennifer Doudna on Future of Biotech
Bloomberg - 10 Feb 2022
CRISPR Co-Founder Jennifer Doudna on Future of Biotech ...
Nobel Prize winner to deliver science talk
University of California, Riverside - 12 Jan 2022
Nobel Prize winner to deliver science talk ...
UCSF-led Team Wins $112M NIH Grant to Harness Omics Tools for Antiviral Target, Drug Development
GenomeWeb - 24 May 2022
UCSF-led Team Wins $112M NIH Grant to Harness Omics Tools for Antiviral Target, Drug Development ...
UC Berkeley loses CRISPR gene editing patent case
The Mercury News - 28 Feb 2022
UC Berkeley loses CRISPR gene editing patent case ...